These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21981760)

  • 1. Generation of CD34+ cells from CCR5-disrupted human embryonic and induced pluripotent stem cells.
    Yao Y; Nashun B; Zhou T; Qin L; Qin L; Zhao S; Xu J; Esteban MA; Chen X
    Hum Gene Ther; 2012 Feb; 23(2):238-42. PubMed ID: 21981760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.
    Li L; Krymskaya L; Wang J; Henley J; Rao A; Cao LF; Tran CA; Torres-Coronado M; Gardner A; Gonzalez N; Kim K; Liu PQ; Hofer U; Lopez E; Gregory PD; Liu Q; Holmes MC; Cannon PM; Zaia JA; DiGiusto DL
    Mol Ther; 2013 Jun; 21(6):1259-69. PubMed ID: 23587921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and genetic engineering of human induced pluripotent stem cells using designed zinc finger nucleases.
    Ramalingam S; London V; Kandavelou K; Cebotaru L; Guggino W; Civin C; Chandrasegaran S
    Stem Cells Dev; 2013 Feb; 22(4):595-610. PubMed ID: 22931452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene editing of human embryonic stem cells via an engineered baculoviral vector carrying zinc-finger nucleases.
    Lei Y; Lee CL; Joo KI; Zarzar J; Liu Y; Dai B; Fox V; Wang P
    Mol Ther; 2011 May; 19(5):942-50. PubMed ID: 21326219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
    Holt N; Wang J; Kim K; Friedman G; Wang X; Taupin V; Crooks GM; Kohn DB; Gregory PD; Holmes MC; Cannon PM
    Nat Biotechnol; 2010 Aug; 28(8):839-47. PubMed ID: 20601939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells.
    van Rensburg R; Beyer I; Yao XY; Wang H; Denisenko O; Li ZY; Russell DW; Miller DG; Gregory P; Holmes M; Bomsztyk K; Lieber A
    Gene Ther; 2013 Feb; 20(2):201-14. PubMed ID: 22436965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of CCR5-ablated Human Induced Pluripotent Stem Cells as a Therapeutic Approach for Immune-mediated Diseases.
    Hosseini Rouzbahani N; Kaviani S; Vasei M; Soleimani M; Azadmanesh K; Nicknam MH
    Iran J Allergy Asthma Immunol; 2019 Jun; 18(3):310-319. PubMed ID: 31522438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection.
    Ye L; Wang J; Beyer AI; Teque F; Cradick TJ; Qi Z; Chang JC; Bao G; Muench MO; Yu J; Levy JA; Kan YW
    Proc Natl Acad Sci U S A; 2014 Jul; 111(26):9591-6. PubMed ID: 24927590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted transgene insertion into the AAVS1 locus driven by baculoviral vector-mediated zinc finger nuclease expression in human-induced pluripotent stem cells.
    Tay FC; Tan WK; Goh SL; Ramachandra CJ; Lau CH; Zhu H; Chen C; Du S; Phang RZ; Shahbazi M; Fan W; Wang S
    J Gene Med; 2013 Oct; 15(10):384-95. PubMed ID: 24105820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template.
    Sather BD; Romano Ibarra GS; Sommer K; Curinga G; Hale M; Khan IF; Singh S; Song Y; Gwiazda K; Sahni J; Jarjour J; Astrakhan A; Wagner TA; Scharenberg AM; Rawlings DJ
    Sci Transl Med; 2015 Sep; 7(307):307ra156. PubMed ID: 26424571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34 stem cell stories and lessons from the CD34 wars: the Landsteiner Lecture 2009.
    Civin CI
    Transfusion; 2010 Sep; 50(9):2046-56. PubMed ID: 20561292
    [No Abstract]   [Full Text] [Related]  

  • 12. TALEN-mediated generation and genetic correction of disease-specific human induced pluripotent stem cells.
    Ramalingam S; Annaluru N; Kandavelou K; Chandrasegaran S
    Curr Gene Ther; 2014; 14(6):461-72. PubMed ID: 25245091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging.
    Wang Y; Zhang WY; Hu S; Lan F; Lee AS; Huber B; Lisowski L; Liang P; Huang M; de Almeida PE; Won JH; Sun N; Robbins RC; Kay MA; Urnov FD; Wu JC
    Circ Res; 2012 Dec; 111(12):1494-503. PubMed ID: 22967807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV.
    Almeida MJ; Matos A
    Curr HIV Res; 2019; 17(5):306-323. PubMed ID: 31652113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
    Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
    Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases.
    Hockemeyer D; Soldner F; Beard C; Gao Q; Mitalipova M; DeKelver RC; Katibah GE; Amora R; Boydston EA; Zeitler B; Meng X; Miller JC; Zhang L; Rebar EJ; Gregory PD; Urnov FD; Jaenisch R
    Nat Biotechnol; 2009 Sep; 27(9):851-7. PubMed ID: 19680244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted genome editing in pluripotent stem cells using zinc-finger nucleases.
    Bobis-Wozowicz S; Osiak A; Rahman SH; Cathomen T
    Methods; 2011 Apr; 53(4):339-46. PubMed ID: 21185378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5.
    Maier DA; Brennan AL; Jiang S; Binder-Scholl GK; Lee G; Plesa G; Zheng Z; Cotte J; Carpenito C; Wood T; Spratt SK; Ando D; Gregory P; Holmes MC; Perez EE; Riley JL; Carroll RG; June CH; Levine BL
    Hum Gene Ther; 2013 Mar; 24(3):245-58. PubMed ID: 23360514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis.
    Hong SH; Lee JH; Lee JB; Ji J; Bhatia M
    J Cell Sci; 2011 May; 124(Pt 9):1445-52. PubMed ID: 21486943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells.
    Zou J; Maeder ML; Mali P; Pruett-Miller SM; Thibodeau-Beganny S; Chou BK; Chen G; Ye Z; Park IH; Daley GQ; Porteus MH; Joung JK; Cheng L
    Cell Stem Cell; 2009 Jul; 5(1):97-110. PubMed ID: 19540188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.